# Global X China Biotech Innovation ETF (CHB)

Source: https://www.quantisnow.com/company/CHB
Generated: 2026-11-18T17:11:53.169Z

- Ticker: CHB
- Exchange: NASDAQ
- Sector: n/a
- Industry: n/a
- IPO year: n/a

## About

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index ("underlying index").
 The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in Chinaâs biotechnology industry. It is non-diversified.

## Latest CHB news and filings

- 2024-01-19 21:37 UTC [Global X ETFs To Liquidate 19 ETFs](https://www.quantisnow.com/insight/global-x-etfs-to-liquidate-19-etfs-5196642)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CHB
- Earnings history: https://www.quantisnow.com/earnings/CHB
- Dividend history: https://www.quantisnow.com/dividends/CHB
- Insider transactions: https://www.quantisnow.com/insiders/CHB
- Options chain: https://www.quantisnow.com/options/CHB
- SEC 8-K filings only: https://www.quantisnow.com/company/CHB/8-k
- RSS and alerts for CHB: https://www.quantisnow.com/docs/rss-feeds.md
